Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy
- 10 March 2011
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 150 (2), 212-219
- https://doi.org/10.1016/j.jconrel.2010.11.018
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 27 references indexed in Scilit:
- In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil deliveryDrug Delivery, 2010
- Liposomes modified with YIGSR peptide for tumor targetingJournal of Drug Targeting, 2009
- Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite CapabilitiesAngewandte Chemie-International Edition, 2009
- Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracilBiomedical Microdevices, 2009
- Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft TumorsClinical Cancer Research, 2008
- Transferrin-conjugated liposomal system for improved delivery of 5-fluorouracil to brainJournal of Drug Targeting, 2008
- Cu(II) Complexes with Heterocyclic Substituted Thiosemicarbazones: The Case of 5-Formyluracil. Synthesis, Characterization, X-ray Structures, DNA Interaction Studies, and Biological ActivityInorganic Chemistry, 2003
- 5-Fluorouracil: various kinds of loaded liposomes: encapsulation efficiency, storage stability and fusogenic propertiesInternational Journal of Pharmaceutics, 1993
- Binding of sulfonated fluorophors by metal-polyethylenimine complexesMacromolecules, 1986
- Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potentialBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985